About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

UCB Cimzia Pregnancy Follow-up Study | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNCT02775656

UCB Cimzia Pregnancy Follow-up Study

The purpose of this observational follow-up study is to collect data systematically on pregnancies and offspring of women who become pregnant while participating in a Certolizumab Pegol (CZP) study or...

Lead sponsor: UCB BIOSCIENCES, Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

UCB BIOSCIENCES, Inc.

Collaborators

Syneos Health
Parexel

Age

18 - 64 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Pregnancy is identified while the patient is participating in an interventional or noninterventional Certolizumab Pegol (CZP) study conducted by UCB, or a development partner, regardless of phase or treatment arm (ie, commercial or investigational, placebo or comparator treatment), or whose pregnancies were spontaneously reported to UCB due to potential CZP exposure during pregnancy
•Sufficient information to classify the pregnancy as prospective or retrospective is available
•Full initial reporter (ie, woman or healthcare provider (HCP)) contact information reported to allow for follow-up (name, address, telephone number/email address) and contact information for at least 1 applicable HCP if initial contact is the woman
•Consent to participate is provided

Exclusion Criteria

•Pregnancies in which the resulting infant is over 1 year of age at the time of informed consent will not be eligible to participate in the study

Related studies

Oxidative Stress in Autoimmune Rheumatic Diseases

NCT07536529 · Inflammatory Joint Diseases, Rheumatoid Arthritis (RA), and more

RECRUITINGPhase 1/2

A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease

NCT07048197 · Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD)

RECRUITINGPhase 1

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

NCT06647069 · Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA)

Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis

NCT07484243 · Rheumatoid Arthritis (RA), Rheumatoid Arthritis-Associated Interstitial Lung Disease, and more

Plant-Based Diet for Patients With Rheumatoid Arthritis

NCT07268326 · Rheumatoid Arthritis (RA)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 22, 2021Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment1

Start dateNov 2016

Last updatedApr 22, 2021

Condition

Rheumatoid Arthritis (RA)Crohn's Disease (CD)Psoriatic Arthritis (PsA)Axial Spondyloarthritis and Ankylosing Spondylitis

Locations shown

Up0019 001

Wilmington, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 22, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions